Page last updated: 2024-10-21

5-hydroxydecanoate and Ventricular Dysfunction, Left

5-hydroxydecanoate has been researched along with Ventricular Dysfunction, Left in 2 studies

5-hydroxydecanoic acid: Potassium Channel Blocker; RN refers to parent cpd

Ventricular Dysfunction, Left: A condition in which the LEFT VENTRICLE of the heart was functionally impaired. This condition usually leads to HEART FAILURE; MYOCARDIAL INFARCTION; and other cardiovascular complications. Diagnosis is made by measuring the diminished ejection fraction and a depressed level of motility of the left ventricular wall.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ma, H1
Huang, X1
Li, Q1
Guan, Y1
Yuan, F1
Zhang, Y1
Brown, DA1
Chicco, AJ1
Jew, KN1
Johnson, MS1
Lynch, JM1
Watson, PA1
Moore, RL1

Other Studies

2 other studies available for 5-hydroxydecanoate and Ventricular Dysfunction, Left

ArticleYear
ATP-dependent potassium channels and mitochondrial permeability transition pores play roles in the cardioprotection of theaflavin in young rat.
    The journal of physiological sciences : JPS, 2011, Volume: 61, Issue:4

    Topics: Animals; Atractyloside; Biflavonoids; Cardiotonic Agents; Catechin; Decanoic Acids; Glyburide; Heart

2011
Cardioprotection afforded by chronic exercise is mediated by the sarcolemmal, and not the mitochondrial, isoform of the KATP channel in the rat.
    The Journal of physiology, 2005, Dec-15, Volume: 569, Issue:Pt 3

    Topics: Animals; ATP-Binding Cassette Transporters; Benzamides; Calcium; Decanoic Acids; Female; Heart; Hydr

2005